150 related articles for article (PubMed ID: 11167040)
1. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging.
Lüdemann L; Hamm B; Zimmer C
Magn Reson Imaging; 2000 Dec; 18(10):1201-14. PubMed ID: 11167040
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
4. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI.
Cao Y; Shen Z; Chenevert TL; Ewing JR
J Magn Reson Imaging; 2006 Aug; 24(2):288-96. PubMed ID: 16795091
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas.
Lüdemann L; Grieger W; Wurm R; Budzisch M; Hamm B; Zimmer C
Eur Radiol; 2001; 11(7):1231-41. PubMed ID: 11471617
[TBL] [Abstract][Full Text] [Related]
6. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
[TBL] [Abstract][Full Text] [Related]
8. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modeling of Gd-DTPA extravasation in brain tumors.
Ludemann L; Wurm R; Zimmer C
Invest Radiol; 2002 Oct; 37(10):562-70. PubMed ID: 12352165
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
Dujardin MI; Sourbron SP; Chaskis C; Verellen D; Stadnik T; de Mey J; Luypaert R
J Neuroradiol; 2012 Oct; 39(4):227-35. PubMed ID: 21840059
[TBL] [Abstract][Full Text] [Related]
11. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
12. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
13. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
14. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
16. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
Lee MC; Cha S; Chang SM; Nelson SJ
J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake.
van der Sanden BP; Rozijn TH; Rijken PF; Peters HP; Heerschap A; van der Kogel AJ; Bovée WM
J Cereb Blood Flow Metab; 2000 May; 20(5):861-70. PubMed ID: 10826537
[TBL] [Abstract][Full Text] [Related]
18. Dynamic susceptibility contrast MRI of gliomas.
Aronen HJ; Perkiö J
Neuroimaging Clin N Am; 2002 Nov; 12(4):501-23. PubMed ID: 12687908
[TBL] [Abstract][Full Text] [Related]
19. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
Law M; Young R; Babb J; Pollack E; Johnson G
AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
[TBL] [Abstract][Full Text] [Related]
20. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
